Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 6 April 2021) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

 (PDF, 5MB, 226 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website. 

 

 

Export 2770 results:
[ Author(Desc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
B
S. Borghs, Thieffry, S., Noack-Rink, M., Dedeken, P., Hong, L. S., Byram, L., Logan, J., Chan, J., and Kiri, V., “Health care cost associated with the use of enzyme-inducing and non-enzyme-active antiepileptic drugs in the UK: a long-term retrospective matched cohort study”, BMC Neurol, vol. 17, p. 59, 2017.
S. Borghs, Byram, L., Chan, J., Dedeken, P., Logan, J., Kiri, V., Noack-Rink, M., Patsalos, P. N., and Thieffry, S., “Comparing healthcare cost associated with the use of enzyme-inducing and non-enzyme active antiepileptic drugs in elderly patients with epilepsy in the UK: a long-term retrospective, matched cohort study”, BMC Neurol, vol. 20, p. 7, 2020.
D. Bornand, Toovey, S., Jick, S. S., and Meier, C. R., “The risk of new onset depression in association with influenza–A population-based observational study”, Brain Behav Immun, vol. 53, pp. 131-137, 2016.
A. Bottle, Kim, D., Aylin, P., Cowie, M. R., Majeed, A., and Hayhoe, B., “Routes to diagnosis of heart failure: observational study using linked data in England”, Heart, vol. 104, pp. 600-605, 2018.
A. Bottle, Kim, D., Aylin, P. P., Majeed, F. A., Cowie, M. R., and Hayhoe, B., “Real-world presentation with heart failure in primary care: do patients selected to follow diagnostic and management guidelines have better outcomes?”, Open Heart, vol. 5, p. e000935, 2018.
A. Bottle, Kim, D., Hayhoe, B., Majeed, A., Aylin, P., Clegg, A., and Cowie, M. R., “Frailty and comorbidity predict first hospitalisation after heart failure diagnosis in primary care: population-based observational study in England”, Age Ageing, 2019.
S. Bou-Antoun, Costelloe, C., Honeyford, K., Mazidi, M., Hayhoe, B. W. J., Holmes, A., Johnson, A. P., and Aylin, P., “Age-related decline in antibiotic prescribing for uncomplicated respiratory tract infections in primary care in England following the introduction of a national financial incentive (the Quality Premium) for health commissioners to reduce use of antibiotic”, J Antimicrob Chemother, vol. 73, pp. 2883-2892, 2018.
G. Bouras, Burns, E. M., Howell, A. M., Bottle, A., Athanasiou, T., and Darzi, A., “Risk of Post-Discharge Venous Thromboembolism and Associated Mortality in General Surgery: A Population-Based Cohort Study Using Linked Hospital and Primary Care Data in England”, PLoS One, vol. 10, p. e0145759, 2015.
G. Bouras, Burns, E. M., Howell, A. M., Bottle, A., Athanasiou, T., and Darzi, A., “Linked hospital and primary care database analysis of the impact of short-term complications on recurrence in laparoscopic inguinal hernia repair”, Hernia, vol. 21, pp. 191-198, 2017.
G. Bouras, Markar, S. R., Burns, E. M., Huddy, J. R., Bottle, A., Athanasiou, T., Darzi, A., and Hanna, G. B., “The psychological impact of symptoms related to esophagogastric cancer resection presenting in primary care: A national linked database study”, Eur J Surg Oncol, vol. 43, pp. 454-460, 2017.
S. Bours, de Vries, F., van den Bergh, J. P. W., Lalmohamed, A., van Staa, T. P., Leufkens, H. G. M., Geusens, P. P. P., Drent, M., and Harvey, N. C., “Risk of vertebral and non-vertebral fractures in patients with sarcoidosis: a population-based cohort”, Osteoporos Int, vol. 27, pp. 1603-1610, 2016.
W. P. Bowe, Hoffstad, O., and Margolis, D. J., “Upper respiratory tract infection in household contacts of acne patients”, Dermatology, vol. 215, pp. 213-8, 2007.
K. Bowman, Delgado, J., Henley, W. E., Masoli, J. A., Kos, K., Brayne, C., Thokala, P., Lafortune, L., Kuchel, G. A., Ble, A., and Melzer, D., “Obesity in Older People With and Without Conditions Associated With Weight Loss: Follow-up of 955,000 Primary Care Patients”, J Gerontol A Biol Sci Med Sci, vol. 72, pp. 203-209, 2017.
K. Bowman, Jones, L., Masoli, J., Mujica-Mota, R., Strain, D., Butchart, J., Valderas, J. M., Fortinsky, R. H., Melzer, D., and Delgado, J., “Predicting incident delirium diagnoses using data from primary-care electronic health records”, Age Ageing, vol. 49, pp. 374-381, 2020.
N. Boxall, Bennett, D., Hunger, M., Dolin, P., and Thompson, P. L., “Evaluation of exposure to pioglitazone and risk of prostate cancer: a nested case-control study”, BMJ Open Diabetes Res Care, vol. 4, p. e000303, 2016.
P. Boyle, Roehrborn, C., Harkaway, R., Logie, J., de la Rosette, J., and Emberton, M., “5-Alpha reductase inhibition provides superior benefits to alpha blockade by preventing AUR and BPH-related surgery”, Eur Urol, vol. 45, pp. 620-6; discussion 626-7, 2004.
B. D. Bradbury and Jick, S. S., “Itraconazole and fluconazole and certain rare, serious adverse events”, Pharmacotherapy, vol. 22, pp. 697-700, 2002.
B. D. Bradbury and Jick, H., “In vitro fertilization and childhood retinoblastoma”, Br J Clin Pharmacol, vol. 58, pp. 209-11, 2004.
B. D. Bradbury, Lash, T. L., Kaye, J. A., and Jick, S. S., “Tamoxifen and cataracts: a null association”, Breast Cancer Res Treat, vol. 87, pp. 189-96, 2004.
B. D. Bradbury, Lash, T. L., Kaye, J. A., and Jick, S. S., “Tamoxifen-treated breast carcinoma patients and the risk of acute myocardial infarction and newly-diagnosed angina”, Cancer, vol. 103, pp. 1114-21, 2005.
B. D. Bradbury, Wilk, J. B., and Kaye, J. A., “Obesity and the risk of prostate cancer (United States)”, Cancer Causes Control, vol. 16, pp. 637-41, 2005.
M. C. Bradley, Motterlini, N., Padmanabhan, S., Cahir, C., Williams, T., Fahey, T., and Hughes, C. M., “Potentially inappropriate prescribing among older people in the United Kingdom”, BMC Geriatr, vol. 14, p. 72, 2014.
M. C. Bradley, Hughes, C. M., Cantwell, M. M., and Murray, L. J., “Statins and pancreatic cancer risk: a nested case-control study”, Cancer Causes Control, vol. 21, pp. 2093-100, 2010.
M. C. Bradley, Hughes, C. M., Cantwell, M. M., Napolitano, G., and Murray, L. J., “Non-steroidal anti-inflammatory drugs and pancreatic cancer risk: a nested case-control study”, Br J Cancer, vol. 102, pp. 1415-21, 2010.
M. C. Bradley, Murray, L. J., Cantwell, M. M., and Hughes, C. M., “Proton pump inhibitors and histamine-2-receptor antagonists and pancreatic cancer risk: a nested case-control study”, Br J Cancer, vol. 106, pp. 233-9, 2012.
D. C. Braeken, Rohde, G. G., Franssen, F. M., Driessen, J. H., van Staa, T. P., Souverein, P. C., Wouters, E. F., and de Vries, F., “Risk of community-acquired pneumonia in chronic obstructive pulmonary disease stratified by smoking status: a population-based cohort study in the United Kingdom”, Int J Chron Obstruct Pulmon Dis, vol. 12, pp. 2425-2432, 2017.
E. Brankin, Walker, M., Lynch, N., Aspray, T., Lis, Y., and Cowell, W., “The impact of dosing frequency on compliance and persistence with bisphosphonates among postmenopausal women in the UK: evidence from three databases”, Curr Med Res Opin, vol. 22, pp. 1249-56, 2006.
P. Brassard, Wu, J. W., Ernst, P., Dell'Aniello, S., Smiechowski, B., and Suissa, S., “The effect of statins on influenza-like illness morbidity and mortality”, Pharmacoepidemiol Drug Saf, vol. 26, pp. 63-70, 2017.
Y. B. Brauchli, Jick, S. S., Curtin, F., and Meier, C. R., “Association between beta-blockers, other antihypertensive drugs and psoriasis: population-based case-control study”, Br J Dermatol, vol. 158, pp. 1299-307, 2008.
Y. B. Brauchli, Jick, S. S., Curtin, F., and Meier, C. R., “Association between use of thiazolidinediones or other oral antidiabetics and psoriasis: A population based case-control study”, J Am Acad Dermatol, vol. 58, pp. 421-9, 2008.
Y. B. Brauchli, Jick, S. S., and Meier, C. R., “Psoriasis and the risk of incident diabetes mellitus: a population-based study”, Br J Dermatol, vol. 159, pp. 1331-7, 2008.
Y. B. Brauchli, Jick, S. S., Curtin, F., and Meier, C. R., “Lithium, antipsychotics, and risk of psoriasis”, J Clin Psychopharmacol, vol. 29, pp. 134-40, 2009.
Y. B. Brauchli, Jick, S. S., Miret, M., and Meier, C. R., “Psoriasis and risk of incident cancer: an inception cohort study with a nested case-control analysis”, J Invest Dermatol, vol. 129, pp. 2604-12, 2009.
Y. B. Brauchli, Jick, S. S., Miret, M., and Meier, C. R., “Psoriasis and risk of incident myocardial infarction, stroke or transient ischaemic attack: an inception cohort study with a nested case-control analysis”, Br J Dermatol, vol. 160, pp. 1048-56, 2009.
Y. B. Brauchli, Jick, S. S., and Meier, C. R., “Statin use and risk of first-time psoriasis diagnosis”, J Am Acad Dermatol, vol. 65, pp. 77-83, 2011.
R. Brauer, Bhaskaran, K., Chaturvedi, N., Dexter, D. T., Smeeth, L., and Douglas, I., “Glitazone Treatment and Incidence of Parkinson's Disease among People with Diabetes: A Retrospective Cohort Study”, PLoS Med, vol. 12, p. e1001854, 2015.
R. Brauer, Smeeth, L., Anaya-Izquierdo, K., Timmis, A., Denaxas, S. C., Farrington, C. P., Whitaker, H., Hemingway, H., and Douglas, I., “Antipsychotic drugs and risks of myocardial infarction: a self-controlled case series study”, Eur Heart J, vol. 36, pp. 984-92, 2015.
R. Brauer, Herrero-Zazo, M., Barlow, D. J., Gaughran, F., Taylor, D., and Howard, L. M., “Minocycline and the risk of acute psychiatric events in adolescence: A self-controlled case series”, J Psychopharmacol, p. 269881118821852, 2019.
R. Brauer, Ruigomez, A., Klungel, O., Reynolds, R., M. Tepie, F., Smeeth, L., and Douglas, I., “The risk of acute liver injury among users of antibiotic medications: a comparison of case-only studies”, Pharmacoepidemiol Drug Saf, vol. 25 Suppl 1, pp. 39-46, 2016.
R. Brauer, Ruigomez, A., Downey, G., Bate, A., Rodriguez, L. A. Garcia, Huerta, C., Gil, M., de Abajo, F., Requena, G., Alvarez, Y., Slattery, J., de Groot, M., Souverein, P., Hesse, U., Rottenkolber, M., Schmiedl, S., de Vries, F., Tepie, M. F., Schlienger, R., Smeeth, L., Douglas, I., Reynolds, R., and Klungel, O., “Prevalence of antibiotic use: a comparison across various European health care data sources”, Pharmacoepidemiol Drug Saf, vol. 25 Suppl 1, pp. 11-20, 2016.
G. Breart, Cooper, C., Meyer, O., Speirs, C., Deltour, N., and Reginster, J. Y., “Osteoporosis and venous thromboembolism: a retrospective cohort study in the UK General Practice Research Database”, Osteoporos Int, vol. 21, pp. 1181-7, 2010.
S. A. Bremner, Carey, I. M., DeWilde, S., Richards, N., Maier, W. C., Hilton, S. R., Strachan, D. P., and Cook, D. G., “Early-life exposure to antibacterials and the subsequent development of hayfever in childhood in the UK: case-control studies using the General Practice Research Database and the Doctors' Independent Network”, Clin Exp Allergy, vol. 33, pp. 1518-25, 2003.
S. A. Bremner, Carey, I. M., DeWilde, S., Richards, N., Maier, W. C., Hilton, S. R., Strachan, D. P., and Cook, D. G., “Vaccinations, infections and antibacterials in the first grass pollen season of life and risk of later hayfever”, Clin Exp Allergy, vol. 37, pp. 512-7, 2007.
S. A. Bremner, Carey, I. M., DeWilde, S., Richards, N., Maier, W. C., Hilton, S. R., Strachan, D. P., and Cook, D. G., “Infections presenting for clinical care in early life and later risk of hay fever in two UK birth cohorts”, Allergy, vol. 63, pp. 274-83, 2008.
H. Bricout, Torcel-Pagnon, L., Lecomte, C., Almas, M. F., Matthews, I., Lu, X., Wheelock, A., and Sevdalis, N., “Determinants of shingles vaccine acceptance in the United Kingdom”, PLoS One, vol. 14, p. e0220230, 2019.
P. E. Briggs, Praet, C. A., Humphreys, S. C., and Zhao, C., “Impact of UK Medical Eligibility Criteria implementation on prescribing of combined hormonal contraceptives”, J Fam Plann Reprod Health Care, vol. 39, pp. 190-6, 2013.
S. L. Brilleman, Purdy, S., Salisbury, C., Windmeijer, F., Gravelle, H., and Hollinghurst, S., “Implications of comorbidity for primary care costs in the UK: a retrospective observational study”, Br J Gen Pract, vol. 63, pp. e274-82, 2013.
S. L. Brilleman and Salisbury, C., “Comparing measures of multimorbidity to predict outcomes in primary care: a cross sectional study”, Fam Pract, vol. 30, pp. 172-8, 2013.
C. Broadhurst, Rhodes, A. M. L., Harper, P., Perry, D. C., Clarke, N. M. P., and Aarvold, A., “What is the incidence of late detection of developmental dysplasia of the hip in England?”, Bone Joint J, vol. 101-b, pp. 281-287, 2019.
M. J. Brodie, Chung, S., Wade, A., Quelen, C., Guiraud-Diawara, A., Francois, C., Verpillat, P., Shen, V., and Isojarvi, J., “Clobazam and clonazepam use in epilepsy: Results from a UK database incident user cohort study”, Epilepsy Res, vol. 123, pp. 68-74, 2016.
[Page last reviewed 6 April 2021]